Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK)
HKD 0.16
(7.53%)
HKD 0.16
(7.53%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.01 CNY | -55.56% |
| 2022 | 0.03 CNY | 51.4% |
| 2021 | 0.02 CNY | -1.83% |
| 2020 | 0.02 CNY | -38.76% |
| 2019 | 0.04 CNY | 24.04% |
| 2018 | 0.03 CNY | -4.33% |
| 2017 | 0.03 CNY | -19.79% |
| 2016 | 0.04 CNY | 199.2% |
| 2015 | 0.01 CNY | -36.87% |
| 2014 | 0.02 CNY | -7.48% |
| 2013 | 0.02 CNY | 47.59% |
| 2012 | 0.01 CNY | 12.4% |
| 2011 | 0.01 CNY | 143.0% |
| 2010 | -0.03 CNY | 24.24% |
| 2009 | -0.04 CNY | -22.6% |
| 2008 | -0.03 CNY | -44.2% |
| 2007 | -0.02 CNY | 18.25% |
| 2006 | -0.03 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.01 CNY | 190.55% |
| 2024 Q2 | 0.01 CNY | -3.48% |
| 2023 Q2 | 0.01 CNY | -16.49% |
| 2023 FY | - CNY | -55.56% |
| 2023 Q3 | 0.01 CNY | 14.81% |
| 2023 Q1 | 0.01 CNY | -45.2% |
| 2023 Q4 | -0.01 CNY | -236.56% |
| 2022 FY | - CNY | 51.4% |
| 2022 Q4 | 0.02 CNY | 90.32% |
| 2022 Q1 | 0.01 CNY | 36.96% |
| 2022 Q2 | 0.00 CNY | -39.68% |
| 2022 Q3 | 0.01 CNY | 144.74% |
| 2021 Q1 | 0.01 CNY | 93.75% |
| 2021 Q4 | 0.00 CNY | 39.39% |
| 2021 Q3 | 0.00 CNY | 37.5% |
| 2021 FY | - CNY | -1.83% |
| 2021 Q2 | 0.00 CNY | -74.19% |
| 2020 Q4 | 0.00 CNY | -21.31% |
| 2020 FY | - CNY | -38.76% |
| 2020 Q1 | 0.01 CNY | -60.0% |
| 2020 Q2 | 0.01 CNY | -5.36% |
| 2020 Q3 | 0.01 CNY | 15.09% |
| 2019 Q3 | 0.01 CNY | 176.32% |
| 2019 Q2 | 0.00 CNY | -47.22% |
| 2019 FY | - CNY | 24.04% |
| 2019 Q1 | 0.01 CNY | -39.5% |
| 2019 Q4 | 0.01 CNY | 33.33% |
| 2018 Q1 | 0.01 CNY | -16.48% |
| 2018 FY | - CNY | -4.33% |
| 2018 Q4 | 0.01 CNY | 54.55% |
| 2018 Q3 | 0.01 CNY | 450.0% |
| 2018 Q2 | 0.00 CNY | -81.58% |
| 2017 FY | - CNY | -19.79% |
| 2017 Q3 | 0.01 CNY | 19.05% |
| 2017 Q2 | 0.01 CNY | -11.27% |
| 2017 Q1 | 0.01 CNY | -58.72% |
| 2017 Q4 | 0.01 CNY | 21.33% |
| 2016 Q1 | 0.01 CNY | 50.0% |
| 2016 Q2 | 0.01 CNY | 13.33% |
| 2016 Q3 | 0.01 CNY | 8.82% |
| 2016 FY | - CNY | 199.2% |
| 2016 Q4 | 0.02 CNY | 132.43% |
| 2015 Q1 | 0.01 CNY | 333.33% |
| 2015 Q2 | 0.00 CNY | -72.31% |
| 2015 FY | - CNY | -36.87% |
| 2015 Q4 | 0.00 CNY | 90.48% |
| 2015 Q3 | 0.00 CNY | 16.67% |
| 2014 FY | - CNY | -7.48% |
| 2014 Q2 | 0.01 CNY | -14.29% |
| 2014 Q4 | 0.00 CNY | -68.09% |
| 2014 Q3 | 0.00 CNY | -28.79% |
| 2014 Q1 | 0.01 CNY | 692.31% |
| 2013 FY | - CNY | 47.59% |
| 2013 Q4 | -0.00 CNY | -146.43% |
| 2013 Q1 | 0.01 CNY | 376.92% |
| 2013 Q3 | 0.00 CNY | -77.95% |
| 2013 Q2 | 0.01 CNY | 76.39% |
| 2012 Q2 | 0.01 CNY | 81.48% |
| 2012 Q4 | -0.00 CNY | -236.84% |
| 2012 Q3 | 0.00 CNY | -80.61% |
| 2012 Q1 | 0.01 CNY | 437.5% |
| 2012 FY | - CNY | 12.4% |
| 2011 Q3 | 0.01 CNY | 1255.56% |
| 2011 FY | - CNY | 143.0% |
| 2011 Q1 | 0.00 CNY | 115.85% |
| 2011 Q2 | 0.00 CNY | -30.77% |
| 2011 Q4 | -0.00 CNY | -113.11% |
| 2010 Q1 | -0.01 CNY | 15.93% |
| 2010 FY | - CNY | 24.24% |
| 2010 Q4 | -0.01 CNY | -555.56% |
| 2010 Q3 | 0.00 CNY | 118.95% |
| 2010 Q2 | -0.01 CNY | 0.0% |
| 2009 Q2 | -0.01 CNY | 0.0% |
| 2009 Q3 | -0.01 CNY | -21.15% |
| 2009 FY | - CNY | -22.6% |
| 2009 Q4 | -0.01 CNY | 10.32% |
| 2008 FY | - CNY | -44.2% |
| 2007 FY | - CNY | 18.25% |
| 2006 FY | - CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 0.34 HKD | 95.765% |
| Grand Pharmaceutical Group Limited | 0.54 HKD | 97.333% |
| Extrawell Pharmaceutical Holdings Limited | -0.07 HKD | 121.114% |
| Wai Yuen Tong Medicine Holdings Limited | -0.01 HKD | 210.769% |
| Qianhai Health Holdings Limited | -0.03 HKD | 146.302% |
| Lee's Pharmaceutical Holdings Limited | 0.03 HKD | 49.296% |
| Essex Bio-Technology Limited | 0.49 HKD | 97.061% |
| Tongfang Kontafarma Holdings Limited | -0.01 HKD | 376.923% |
| PuraPharm Corporation Limited | -0.27 HKD | 105.333% |
| SSY Group Limited | 0.44 HKD | 96.727% |
| JBM (Healthcare) Limited | 0.15 HKD | 90.4% |
| Jacobson Pharma Corporation Limited | 0.12 HKD | 88.0% |
| China Resources Pharmaceutical Group Limited | 0.68 HKD | 97.882% |